• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A rational treatment of stage I epithelial ovarian cancer].

作者信息

Wang W, Huo R

机构信息

Affiliated Hospital of Bengbu Medical College.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 1996 Jul;31(7):387-9.

PMID:9275407
Abstract

OBJECTIVE

To evaluate the incidence of lymph node metastasis and the role of lymphadenectomy in stage I epithelial ovarian cancer.

METHODS

Forty patients with stage I epithelial ovarian cancer treated from 1985 to 1990, were divided into two groups and retrospectively analyzed. First group of 20 patients were treated by routine surgery and cis-platinum based chemotherapy. Second group of 20 patients were treated by routine surgery and cis-platinum based chemotherapy plus retroperitoneal lymphadenectomy, and on the basis of with normal ovary and uterus preserved in the younger stage I a patients. A comparison was made between the five-year survival rates of the two groups.

RESULTS

Four patients in the second group were found to have retroperitoneal lymph node metastasis and should be staged as II c postoperatively. In three of the four patients aortic lymph node metastasis were diagnosed. The chances of metastasis to the pelvic and to the aortic lymph nodes were nearly equal. There is a significant difference in the 5-year survival rates between the two groups (85% vs 100%, P < 0.05). Ten patients with their ovaries and uteri preserved are living and well.

CONCLUSION

It is suggested that to obtain accurate FIGO staging and to improve survival and its quality, retroperitoneal lymphadenectomy should be performed in all patients with stage I eipthelial ovarian cancer, and younger patients with stage I a cancer may preserve their gestational functions if desired.

摘要

相似文献

1
[A rational treatment of stage I epithelial ovarian cancer].
Zhonghua Fu Chan Ke Za Zhi. 1996 Jul;31(7):387-9.
2
Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.淋巴管间隙浸润和主动脉旁阳性淋巴结组数量可预测子宫内膜癌淋巴结阳性患者的生存率。
Gynecol Oncol. 2005 Mar;96(3):651-7. doi: 10.1016/j.ygyno.2004.11.026.
3
[Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].[化疗对上皮性卵巢癌淋巴结转移的临床疗效分析]
Ai Zheng. 2003 Apr;22(4):424-7.
4
Lymph node metastasis in stage I epithelial ovarian cancer.Ⅰ期上皮性卵巢癌的淋巴结转移
Gynecol Oncol. 2000 Nov;79(2):305-8. doi: 10.1006/gyno.2000.5951.
5
[Retroperitoneal lymph node metastasis in epithelial cancer of the ovary: a report of 58 cases].[卵巢上皮癌腹膜后淋巴结转移:58例报告]
Zhonghua Zhong Liu Za Zhi. 2004 Aug;26(8):499-501.
6
[A rational selection of retroperitoneal lymphadenectomy for advanced epithelial ovarian cancer].[晚期上皮性卵巢癌腹膜后淋巴结切除术的合理选择]
Zhonghua Fu Chan Ke Za Zhi. 1999 Feb;34(2):108-9.
7
[The clinical significance of retroperitoneal lymph node metastasis and lymphadenectomy on 3-year survival in ovarian carcinoma].[腹膜后淋巴结转移及淋巴结切除术对卵巢癌3年生存率的临床意义]
Nihon Sanka Fujinka Gakkai Zasshi. 1993 Oct;45(10):1095-100.
8
The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.探讨影响 IIIC 期和 IV 期上皮性卵巢癌腹膜后淋巴结转移的因素。
Arch Gynecol Obstet. 2009 Dec;280(6):939-44. doi: 10.1007/s00404-009-1038-8. Epub 2009 Mar 21.
9
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.系统主动脉和盆腔淋巴结清扫术与仅切除减瘤至最佳状态的晚期卵巢癌肿大淋巴结的比较:一项随机临床试验。
J Natl Cancer Inst. 2005 Apr 20;97(8):560-6. doi: 10.1093/jnci/dji102.
10
[The surgical treatment of ovarian cancer].
Geburtshilfe Frauenheilkd. 1990 Sep;50(9):670-7. doi: 10.1055/s-2008-1026343.